amarillo biosciences inc (FZX) Snapshot

Amarillo Biosciences Inc. announced resignation of Dr. Joseph M Cummins as President and COO of the company effective November 30, 2012. As of December 1, 2012 he will begin working for the company as a consultant.

Amarillo Biosciences Inc.’s common stock has been deleted from OTC Bulletin Board (OTCBB) effective July 23, 2012 on account of its ineligibility for quotation on OTCBB due to quoting inactivity under SEC Rule 15c2-11.

Amarillo Biosciences Inc. announced a plan to open its Asia Operations Center in Taipei, Taiwan. This new center will enable ABI to increase its presence in Taiwan in order to access growing markets in mainland China and in other Asian countries. The mission of the Asia Operations Center is fourfold. First, the Asia Center will introduce novel healthcare products and technologies from the U.S. into the Asian markets. Second, the Asia Center will be responsible for identifying and developing new strategic partners in the region. Third, the Center will be poised to seek out new sources of financing when the need arises. Fourth, the Asia Center will identify new healthcare products and technologies that can be brought into the U.S. from the Asian regions to be distributed by ABI.